$Morningstar(MORN)A 40-year "slow company," has been cut in half by the market to $180—yet the founder remains at a 38% position without moving.

A Strange Contradiction

In December 2024, Morningstar (NASDAQ: MORN)
$MORN stock price hit an all-time high of $354.

By April 17, 2026, when I wrote this article, the stock was at $180.52, a 49% haircut.

Meanwhile, how did its peers perform?

S&P Global (SPGI) fell 7%, Moody’s (MCO) rose 3%, MSCI increased 1.5%. Only FactSet (FDS) plunged 47% along with Morningstar.

In other words, the entire “financial data and ratings” high-margin moat track that Buffett’s family has loved for 30 years, only two companies have been thrown into the trash in the past year.

If you stop at this level, the conclusion is simple: The market’s anxiety about AI disruption, combined with PitchBook’s growth slowdown, has priced Morningstar as a growth stock in a valuation kill.

But I want to show you something even stranger.

While the market was frantically selling off:

Founder Joe Mansueto held 37–38% of shares and didn’t sell a single share of his main position (that planned 210k-share reduction accounted for only 1.4% of his total holdings, and he was executing within the $160 range without deviation).

New CFO Michael Holt, on March 4, 2026, bought 1,000 shares himself at $186.59 on the open market.

The company repurchased $787 million worth of its own stock in 2025 at an average price $240 , and in October 2025 authorized a new three-year $210k buyback plan—when the stock price had already fallen near $10 , but this $E2@ buyback hadn’t started yet.

In his 2025 shareholder letter, Mansueto personally wrote: “painful to see the decline, but also created an opportunity to increase our ownership in a business that we know as well as any.”

In other words: The market is selling $180 , insiders are buying $10 , and the founder is telling shareholders in a letter that “this is a good opportunity to add.”

Such divergence is rare. Rare divergences often mean that at least one side—market or insiders—is making a big mistake.

The conclusion upfront:

This is a “growth downgrade” crisis, not a “business model collapse” crisis. The market has priced the former as the latter.

From a 5-year perspective, MORN’s intrinsic value range is $260–$285, optimistic case $380–$415, downside protection $150–$160. Asymmetric odds roughly 1:3 to 1:9.

In this lengthy article, I will try to lay out all the reasoning openly—you can judge for yourself, not blindly follow.

First, a quick intro: What exactly does Morningstar do?

Many friends have heard of “Morningstar ratings,” those stars in the top right corner of funds. But equating Morningstar with just a “fund rating website” underestimates this company’s first-layer bias.

Morningstar was founded in 1984 by Joe Mansueto in his Chicago apartment with $80k. Forty years later, it is today the only independent financial data and research group worldwide spanning six niche tracks:

First: Public market data and terminals. Its flagship product Morningstar Direct is the daily workbench for fund companies, financial advisors, institutional researchers, covering 300k fund shares, 28k ETFs, 40k stocks. In 2024, after adjustments, this segment’s profit margin is 45.1%.

Second: Private market data PitchBook. Acquired in 2016 for $225 million. Today, PitchBook covers 10.1 million private companies, 2.9 million deals, 600k investors. It’s a standard tool for PE/VC due diligence and comparable valuation. In 2025, revenue is about $660 million—nearly 10 times the $225 million invested.

Third: Credit rating DBRS. Acquired in 2019 for $669 million. Now the fourth-largest rating agency in the US, with over 30% market share in commercial mortgage-backed securities (CMBS). In Q4 2025, revenue grew +27.9% YoY, the fastest growth engine of the entire company.

Fourth: ESG research Sustainalytics. Fully acquired in 2020. After ESG hype faded, this segment experienced two rounds of layoffs, but the data assets’ scarcity in the AI era is underestimated.

Fifth: Index business Morningstar Indexes. In February 2026, acquired Chicago University’s CRSP for $365 million—the provider of benchmarks for flagship index funds like Vanguard VTI, VTSAX. This acquisition pushed Morningstar Indexes’ assets under management beyond $4.2 trillion.

Sixth: Retirement business Morningstar Retirement. Provides managed account services for over 2 million 401(k) participants, charging based on assets under management, with a 2024 adjusted profit margin of 51.6%.

Putting these six blocks together, you see that Morningstar is a hybrid company with subscription (70.3%) + ETF (15.7%) + asset-linked (14%) three business models. In 2025, total revenue was $192837465657483.91T (+7.5%), adjusted operating profit $583 million (+18%), free cash flow $443 million.

Compare: S&P Global (SPGI) revenue is $15.3 billion, Moody’s (MCO) $7.7 billion, MSCI $3.1 billion. Morningstar’s scale at $2.4 billion is considered “small to medium” in this circle. But it’s the only independent player that has entered all four legs: private data, credit ratings, ESG, and indexes.

Why did this company get halved? What is the market anxious about?

The market’s worries boil down to three points.

First: PitchBook’s growth is slowing. In Q1 2024, revenue growth was 11.1%, but by Q4 2025, it dropped to 6.2%. This was Morningstar’s star segment, suddenly decelerating. The market’s logic: “PE/VC industry shrinking, product cycle peaked, Preqin’s acquisition by Blackstone increased competition.”

Second: AI anxiety. The concern is: Will ChatGPT, Perplexity, Bloomberg GPT within three years disrupt Morningstar and FDS’s “seat-based” data terminals? The 47% haircut on FDS already priced in this risk, and MORN was dragged down along with it.

Third: High base effect in 2026 YoY. In 2024, the spin-off of TAMP business to AssetMark contributed a one-time gain of $64 million. Starting Q1 2026, quarterly reports will face “not-so-pretty YoY comparisons,” and conservative modeling by institutions will suppress valuation.

Each worry is real. But each is a “growth downgrade,” not a “business model collapse.”

PitchBook’s logic is simple—it’s not losing clients, but losing high-speed growth. Net retention rate (NRR) dropped from 114% in 2023 to 107% in 2024, still healthy. Licenses in Q3 2024 still grew +19% YoY. The real question: after serving top 100 PE funds, top 50 investment banks, top 30 law firms, where is the next growth coming from? The answer: product TAM is extending from “core PE/VC users” to “wealth management, private credit, family offices”—this takes time but is not a business model death.

The counterexample to AI anxiety: The hotter the LLM, the more valuable PitchBook data becomes. Anthropic Claude, OpenAI ChatGPT, Perplexity, Rogo, Hebbia are all paying via MCP protocols to access PitchBook data—because private company info can’t be crawled or fabricated by LLMs. This is entirely different from public market data (which AI can aggregate itself). Similarly, DBRS’s rating data has legal authority, Sustainalytics’s ESG scores are regulatory compliance essentials—these are “licensed / compliant / exclusive” data assets, which are the most valuable parts in the AI era.

High base effect worries are the least meaningful. The market always discounts companies with no growth based on TTM data, and then overhypes them after exceeding expectations. This is emotional pricing, not fundamentals.

But the most core evidence in this article—management

If I had to pick just one reason to buy MORN at $180 , it would be “management.”

Joe Mansueto’s shareholding structure and compensation design are the most thorough alignment of interests I’ve seen among US small- and mid-cap shareholders.

Mansueto owns about 14.57 million shares of MORN, accounting for 37–38% of 38.5 million total shares, with a market cap of roughly $2.66 billion—almost his entire net worth.

In 2023, as Executive Chairman, his total annual compensation was: $105,250. No typo—just one hundred five thousand two hundred fifty dollars. Cash salary, plus a few thousand in benefits, zero equity grants.

In other words: all his returns are 100% tied to his 38% stake. No salary, no bonus, no options—if the company’s stock rises, he profits; if it falls, he loses together.

This compensation structure means: You never need to worry about him doing short-term actions that harm long-term shareholders. You also never need to worry about him manipulating the stock with “adjusted earnings forecasts” tricks—because for him, long-term market value is the only wealth preservation tool.

As for the 212k shares he plans to reduce via a 10b5-1 pre-arranged plan from August 2025 to March 2026 (cash-out about $420–$192837465657483.91T)—two key points:

First, this plan was set in November 2024 when the stock was around $180 , and he cannot cancel it arbitrarily;

Second, this reduction only accounts for 1.4% of his total holdings, and he continued to sell within the $155–$180 range as planned. If he truly believed the company’s fundamentals had collapsed, he wouldn’t let himself be forced to sell at half-peak—he would just cancel the plan. The real purpose of this reduction is for GRAT trust annuity payments and estate tax planning, unrelated to his confidence in the company.

Looking at CEO Kunal Kapoor. Born in 1975, of Indian descent, CFA charterholder, joined Morningstar as a data analyst in 1997—not the usual story of 2000. He cultivated within the company for 20 years, serving as Director of Fund Research, founding team of Morningstar Investment Services, International Business Strategy Director, Global Data Head, President, and took over as CEO in 2017.

His three most important capital allocation decisions:

PitchBook acquisition—A+. Paid $225 million in 2016. Today, PitchBook alone, based on Blackstone’s 2024 valuation of $3.2 billion (13x revenue), implied valuation is about $8 billion. A $80k investment, nearly 35x return over 10 years.

DBRS acquisition—A. Paid $669 million in 2019. In 2025, credit revenue is about $355 million, still an “accelerating credit rating asset”—principal mostly recovered, remaining is compound growth.

CRSP acquisition—B+. In February 2026, bought Chicago’s Center for Research in Security Prices for $365 million, core value: capturing benchmarks for trillion-dollar index funds like Vanguard VTI/VTSAX. This gave Morningstar Indexes an asset-based fee curve, similar to MSCI.

What impresses me even more is that Morningstar’s compensation committee truly punishes CEOs.

In May 2022, Kapoor was granted MSU equity incentives, with 3-year TSR linked, and only 82.0% vested; in November 2022, that batch only vested 28.8%. In 2025, Kapoor could receive 115.5% of annual bonus per formula, but the compensation committee actively reduced it to 111.4%—citing “a small number of delayed product deliveries.” Just because a few products were late.

In the US stock CEO ecosystem, where bonuses are often fully paid regardless of performance, this “real penalty” mechanism is rare. It shows two things: one, the board’s independence is genuine; two, the company takes “promise—delivery—fulfillment” seriously.

One last detail—new CFO Michael Holt. He took over in January 2025, with 17 years at Morningstar since 2008. On March 4, 2026, he bought 1,000 shares at $186.59 on the open market with his own money, currently holding 9,480 shares.

A new CFO buying stock near $180 with his own funds is very rare among US small- and mid-cap stocks—an open-market purchase (not options exercise or limit-and-hold) signals “I believe the current price is below intrinsic value, and I am willing to put my own money on this judgment.”

Valuation: 14 methods cross-validated—what’s a reasonable price?

I used 14 valuation methods across four categories for cross-checking, all figures here for your reference.

Sum-of-the-parts (SOTP) is the most relevant—because the company’s six business lines have completely different valuation logic. Conservative assumptions: PitchBook at 5x revenue, DBRS at 14x EBITDA (Moody’s level), Direct Platform at FactSet multiples, Indexes at MSCI multiples, summed to an intrinsic value of about $307 per share. Neutral assumptions: PitchBook at 9x revenue—$384. Optimistic: PitchBook at 13x (like Preqin)—$415.

DCF realistic scenario: 2026–2030 FCF growth 9–10%, WACC 9%, perpetual growth 2.75%, per share value $220. Pessimistic: FCF growth 5%, WACC 9.5%—$158—a key anchor, indicating that if Morningstar barely grows over 5 years, ( is a fair price.

Owner earnings (Buffett style): FY2025 net profit $374 million + D&A $190 million – CapEx $147 million – change in working capital, yields $346 million. Divided by 42 million diluted shares, about $8.20 per share, multiplied by 18–25x reasonable multiple = $147–$205.

EV/EBITDA relative valuation: industry median 19x → $309; conservative use SPGI’s current 16.5x → $267; Morningstar’s 10-year median 17.3x → $281.

P/E relative valuation: 2026E EPS estimate $11.35, applying 24x (well below SPGI, MCO, MSCI levels) → $272.

Replacement cost (Greenwald method): summing the database, brand, customer relationships, employee capital as if a rational entrant rebuilds from zero—about $224—a hard bottom unlikely to fall below.

Crossing all 14 methods, the valuation distribution:

Scenario Valuation Range Space from current $180.52

Pessimistic bear market $155–) -14% to -3%

**Neutral baseline $240–$180 +33% to +58%

Optimistic bull market $360–$280 +99% to +130%

The median fair value is roughly $260, close to the sell-side consensus of $256.5. UBS rates it Buy, BMO Outperform.

The key attraction of this trade is the asymmetric odds: 14% downside (to $155), 44% neutral (around $260), up to 130% upside (around $415). Odds roughly 1:3 to 1:9.

Catalysts and risks—I won’t hide them

Catalysts, ordered by probability:

Short-term: Q1 2026 earnings on April 29 will verify if PitchBook stabilizes; if the $E2@ buyback plan is aggressively executed in the $180 range, it could shrink share count by 14%; Fed’s continued rate cuts in 2026 could sustain 25%+ high growth in DBRS.

Medium-term: CRSP integration completes, Indexes business begins to realize asset-based fee growth; if PitchBook resumes double-digit growth in late 2026, market sentiment will quickly recover; Morningstar Wealth turns profitable.

Long-term: Mansueto is 69 this year. In 3–5 years, clarity on succession will unlock a “discount for founder retirement uncertainty.”

And risks:

If PitchBook’s growth permanently stabilizes at 5–8%, my optimistic valuation would need to be lowered to $180 ; if AI truly develops a product within 3 years that replaces the Direct terminal and gains industry recognition, the seat-based model will be squeezed; Sustainalytics’s ESG business shows no signs of revival short-term; mishandling Mansueto’s succession (e.g., selling controlling stake to private equity) could cause short-term liquidity shocks.

I don’t think these risks will break $175 below $150—but they could slow valuation recovery by 12–18 months.

5-year 10x upside? My honest answer

Applying my “hold for 5 years, 10x upside” principle:

Revenue 10x in 5 years would mean going from 300k to 28k—requiring a 58% annual growth, which is unrealistic.

Stock price 10x in 5 years would mean hitting $1,800—requiring extreme optimism in both valuation multiple and performance, low probability.

But I believe there’s over 70% chance the stock will be 1.5–2.5x higher in 5 years (to $270–$450). If AI narrative reverses + PitchBook re-accelerates compounding + CRSP fully monetizes, 3x (to $540) is also possible.

In other words: MORN is not a typical “10x stock” candidate in my framework—its business structure doesn’t support that. But it’s a mispriced, downside-protected, compound-quality asset. Such assets are best positioned as “core holdings in a long-term portfolio, low-volatility anchors,” not “aggressive 10x growth stocks in 5 years.”

Honestly, I’d reserve the 10x target for crypto leaders that have been miskilled. MORN in my stock portfolio plays a different role: a counter-cyclical compound anchor, a rebalancing tool during extreme sentiment, a safe bottom position for 5 years without watching the market.

Conclusion: Patience against emotions

Buffett wrote in his 1989 shareholder letter: “Time is the friend of the wonderful business, the enemy of the mediocre.”

Today, Morningstar is a good business that has never changed its mission, never replaced its founder, never faked earnings, never had governance collapse—yet it’s experiencing an “emotional mispricing” because “the time isn’t right yet.”

Wang Yangming said “Unity of knowledge and action.” The knowledge part: the 14 valuation methods tell you $285 is cheap. The action part: whether you believe in the founder’s 38% stake, CFO’s buy, or the company’s $E2@ buyback—these are judgments closer to the information source.

My decision: Build a 3–5% core position. Add to 5–7% if below $415 , to 7–10% if below $280 . Hold for 5 years.

I make no promises on results. But I promise: If any of these signals appear—“PitchBook quarterly growth < 5%”, “NRR drops below 100%”, “CFO/CEO sudden departure”, “management large-scale non-mechanical sell-off”—I will tell you immediately, regardless of whether it’s profit or loss.

This is the essence of “crisis investing and research” versus following the herd: We’re not betting on ups and downs, but on the formula “reversible crisis × emotional mispricing × huge room for growth × patience squared.”

If any factor fails, exit immediately.

⚠: This article is only my personal investment research sharing, not any investment advice!

Creating content is hard. If you’re interested in truly “value stocks,” follow me—I will keep sharing the latest research reports for your review!

[#Crisis Investment Model]

![]$193 https://img-cdn.gateio.im/webp-social/moments-1f1ac76a7d-f0c8d391bc-8b7abd-badf29.webp$10